Cargando…

Monocyte Siglec-14 expression is upregulated in patients with systemic lupus erythematosus and correlates with lupus disease activity

Objective. Siglecs are sialic acid-binding immunoglobulin-like lectins expressed on the surface of immune cells, which participate in the discrimination of self and non-self. We investigated myeloid CD33-related Siglec expression in a cohort of patients with SLE. Methods. Cell surface expression of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thornhill, Susannah I., Mak, Anselm, Lee, Bernett, Lee, Hui Yin, Poidinger, Michael, Connolly, John E., Fairhurst, Anna-Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Basic and Translational Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445601/ https://www.ncbi.nlm.nih.gov/pubmed/28137763 http://dx.doi.org/10.1093/rheumatology/kew498

Ejemplares similares

Brief report: Decreased expression of CD244 (SLAMF4) on monocytes and platelets in patients with systemic lupus erythematosus
por: Mak, Anselm, et al.
Publicado: (2017)

Autophagy is activated in systemic lupus erythematosus and required for plasmablast development
por: Clarke, Alexander J, et al.
Publicado: (2015)

Proportions of B-cell subsets are altered in incomplete systemic lupus erythematosus and correlate with interferon score and IgG levels
por: Henning, Svenja, et al.
Publicado: (2020)

DNA methylation mapping identifies gene regulatory effects in patients with systemic lupus erythematosus
por: Imgenberg-Kreuz, Juliana, et al.
Publicado: (2018)

Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis
por: Leonard, Dag, et al.
Publicado: (2018)

The Pathology of T Cells in Systemic Lupus Erythematosus
por: Mak, Anselm, et al.
Publicado: (2014)

Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis
por: Lyons, Paul A, et al.
Publicado: (2010)

The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus
por: Alexander, Tobias, et al.
Publicado: (2015)

Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples
por: Reddy, Venkat, et al.
Publicado: (2017)

Environmental Factors, Toxicants and Systemic Lupus Erythematosus
por: Mak, Anselm, et al.
Publicado: (2014)

Siglec genes confer resistance to systemic lupus erythematosus in humans and mice
por: Flores, Rhonda, et al.
Publicado: (2018)

Cereblon modulator iberdomide induces degradation of the transcription factors Ikaros and Aiolos: immunomodulation in healthy volunteers and relevance to systemic lupus erythematosus
por: Schafer, Peter H, et al.
Publicado: (2018)

Transancestral mapping of the MHC region in systemic lupus erythematosus identifies new independent and interacting loci at MSH5, HLA-DPB1 and HLA-G
por: Fernando, Michelle M A, et al.
Publicado: (2012)

T Cells, Interleukin-2 and Systemic Lupus Erythematosus—From Pathophysiology to Therapy
por: Mak, Anselm
Publicado: (2022)

Apoptosis-derived membrane vesicles drive the cGAS–STING pathway and enhance type I IFN production in systemic lupus erythematosus
por: Kato, Yasuhiro, et al.
Publicado: (2018)

Serum Midkine Levels in Systemic Lupus Erythematosus
por: Marpaung, Blondina, et al.
Publicado: (2018)

Costimulatory Pathways: Physiology and Potential Therapeutic Manipulation in Systemic Lupus Erythematosus
por: Kow, Nien Yee, et al.
Publicado: (2013)

The rs1143679 (R77H) lupus associated variant of ITGAM (CD11b) impairs complement receptor 3 mediated functions in human monocytes
por: Rhodes, Benjamin, et al.
Publicado: (2012)

Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus
por: Ekman, Carl, et al.
Publicado: (2011)

The Impact of Vitamin D on the Immunopathophysiology, Disease Activity, and Extra-Musculoskeletal Manifestations of Systemic Lupus Erythematosus
por: Mak, Anselm
Publicado: (2018)

2114 Severity of childhood-onset systemic lupus erythematosus: Impact of preceding and co-existing autoimmune cytopenias (protocol)
por: Akan, Ekemini, et al.
Publicado: (2018)

2456 Cutaneous lupus erythematosus patients have increased circulating myeloid-derived suppressor cells with immunosuppressive properties
por: Florez-Pollack, Stephanie, et al.
Publicado: (2018)

Low‐Density Neutrophils in Systemic Lupus Erythematosus
por: Tay, Sen Hee, et al.
Publicado: (2020)

Imbalance between Endothelial Damage and Repair: A Gateway to Cardiovascular Disease in Systemic Lupus Erythematosus
por: Mak, Anselm, et al.
Publicado: (2014)

Update on the Genetics of Systemic Lupus Erythematosus: Genome-Wide Association Studies and Beyond
por: Kwon, Young-Chang, et al.
Publicado: (2019)

Insights into the role of neutrophils in neuropsychiatric systemic lupus erythematosus: Current understanding and future directions
por: Sim, Tao Ming, et al.
Publicado: (2022)

The Progress of Investigating the CD137-CD137L Axis as a Potential Target for Systemic Lupus Erythematosus
por: Mak, Anselm, et al.
Publicado: (2019)

Intrarenal activation of adaptive immune effectors is associated with tubular damage and impaired renal function in lupus nephritis
por: Pamfil, Cristina, et al.
Publicado: (2018)

Early cerebral volume reductions and their associations with reduced lupus disease activity in patients with newly-diagnosed systemic lupus erythematosus
por: Mak, Anselm, et al.
Publicado: (2016)

Cognitive Dysfunction in Systemic Lupus Erythematosus: Immunopathology, Clinical Manifestations, Neuroimaging and Management
por: Seet, Dominic, et al.
Publicado: (2021)

Type I Interferons in Systemic Lupus Erythematosus: A Journey from Bench to Bedside
por: Sim, Tao Ming, et al.
Publicado: (2022)

SIGLEC1 (CD169) is a sensitive biomarker for the deterioration of the clinical course in childhood systemic lupus erythematosus
por: von Stuckrad, Sae Lim, et al.
Publicado: (2020)

Upregulation of microRNA‐762 suppresses the expression of GIPC3 in systemic lupus erythematosus and neuropsychiatric systemic lupus erythematosus
por: Yang, Jijuan, et al.
Publicado: (2022)

Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor α (WSX-1)
por: Sugiyama, N, et al.
Publicado: (2008)

HSC70 blockade by the therapeutic peptide P140 affects autophagic processes and endogenous MHCII presentation in murine lupus
por: Page, Nicolas, et al.
Publicado: (2010)

Siglec-1 expression on monocytes is associated with the interferon signature in juvenile dermatomyositis and can predict treatment response
por: Lerkvaleekul, Butsabong, et al.
Publicado: (2021)

Sex Differences in Monocyte Activation in Systemic Lupus Erythematosus (SLE)
por: Jiang, Wei, et al.
Publicado: (2014)

The Potential Use of Metformin, Dipyridamole, N-Acetylcysteine and Statins as Adjunctive Therapy for Systemic Lupus Erythematosus
por: Tan, Marcus Kai Xuan, et al.
Publicado: (2019)

Toll-like receptors in systemic lupus erythematosus: potential for personalized treatment
por: Celhar, Teja, et al.
Publicado: (2014)

Modelling clinical systemic lupus erythematosus: similarities, differences and success stories
por: Celhar, Teja, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m7ee9ovil3d34chfo5vs36esvs